Causes and risk factors of death in patients with thrombotic microangiopathies View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-07-14

AUTHORS

Vincent Peigne, Pierre Perez, Matthieu Resche Rigon, Eric Mariotte, Emmanuel Canet, Jean-Paul Mira, Paul Coppo, Agnès Veyradier, Elie Azoulay

ABSTRACT

PurposeAlthough plasma therapy of thrombotic micro-angiopathies (TMAs) has dramatically improved survival, the outcome remains fatal in up to 15 % of patients. We investigated the causes and risk factors of death in patients with TMA.MethodsRetrospective matched case–control national-registry study of 57 patients who died within 180 days of TMA diagnosis and 48 survivors matched on age, gender, and baseline platelet count and creatinine level. The study period was 1995–2007. Factors associated with mortality were identified using a conditional logistic regression model.ResultsMedian time from TMA symptom onset to death was 7 (5–14) days. The leading causes of death were nosocomial infections, myocardial infarction, stroke, and pulmonary embolism. Cases and controls did not differ significantly regarding haemolysis parameters, ADAMTS13 activity, or neurological or gastrointestinal involvement. TMA was more frequently related to HIV or cancer in patients who died. Compared to survivors, non-survivors more often had cardiac involvement at diagnosis (38 vs. 6 %, p = 0.03) and less often received plasma exchange therapy (60 vs. 92 %, p = 0.004). Only two factors were independently associated with mortality by multivariate analysis: cardiac involvement at diagnosis (odds ratio, 5.96; 95 % confidence interval, 1.06–33.4) and plasma exchange therapy (odds ratio, 0.25; 95 % confidence interval, 0.06–0.99).ConclusionOur data emphasise the adverse prognostic significance of cardiac abnormalities and support routine plasma exchange in patients with TMA. Given the high risk of cardiac and neurological complications, adequate monitoring should be proposed to these patients in appropriate hospital settings. More... »

PAGES

1810-1817

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00134-012-2638-5

DOI

http://dx.doi.org/10.1007/s00134-012-2638-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042628857

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22797353


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cause of Death", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasma Exchange", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombotic Microangiopathies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peigne", 
        "givenName": "Vincent", 
        "id": "sg:person.01013417670.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013417670.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perez", 
        "givenName": "Pierre", 
        "id": "sg:person.01110107664.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110107664.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Resche Rigon", 
        "givenName": "Matthieu", 
        "id": "sg:person.01036155166.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mariotte", 
        "givenName": "Eric", 
        "id": "sg:person.0705705127.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705705127.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Canet", 
        "givenName": "Emmanuel", 
        "id": "sg:person.0625111723.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625111723.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mira", 
        "givenName": "Jean-Paul", 
        "id": "sg:person.0774634153.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774634153.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coppo", 
        "givenName": "Paul", 
        "id": "sg:person.01031271546.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031271546.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Veyradier", 
        "givenName": "Agn\u00e8s", 
        "id": "sg:person.01073441000.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073441000.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "AP-HP, H\u00f4pital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Azoulay", 
        "givenName": "Elie", 
        "id": "sg:person.01352577613.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352577613.57"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2012-07-14", 
    "datePublishedReg": "2012-07-14", 
    "description": "PurposeAlthough plasma therapy of thrombotic micro-angiopathies (TMAs) has dramatically improved survival, the outcome remains fatal in up to 15\u00a0% of patients. We investigated the causes and risk factors of death in patients with TMA.MethodsRetrospective matched case\u2013control national-registry study of 57 patients who died within 180\u00a0days of TMA diagnosis and 48 survivors matched on age, gender, and baseline platelet count and creatinine level. The study period was 1995\u20132007. Factors associated with mortality were identified using a conditional logistic regression model.ResultsMedian time from TMA symptom onset to death was 7 (5\u201314) days. The leading causes of death were nosocomial infections, myocardial infarction, stroke, and pulmonary embolism. Cases and controls did not differ significantly regarding haemolysis parameters, ADAMTS13 activity, or neurological or gastrointestinal involvement. TMA was more frequently related to HIV or cancer in patients who died. Compared to survivors, non-survivors more often had cardiac involvement at diagnosis (38 vs. 6\u00a0%, p\u00a0=\u00a00.03) and less often received plasma exchange therapy (60 vs. 92\u00a0%, p\u00a0=\u00a00.004). Only two factors were independently associated with mortality by multivariate analysis: cardiac involvement at diagnosis (odds ratio, 5.96; 95\u00a0% confidence interval, 1.06\u201333.4) and plasma exchange therapy (odds ratio, 0.25; 95\u00a0% confidence interval, 0.06\u20130.99).ConclusionOur data emphasise the adverse prognostic significance of cardiac abnormalities and support routine plasma exchange in patients with TMA. Given the high risk of cardiac and neurological complications, adequate monitoring should be proposed to these patients in appropriate hospital settings.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00134-012-2638-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313639", 
        "issn": [
          "0342-4642", 
          "1432-1238"
        ], 
        "name": "Intensive Care Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "cardiac involvement", 
      "exchange therapy", 
      "risk factors", 
      "conditional logistic regression models", 
      "appropriate hospital setting", 
      "baseline platelet count", 
      "national registry study", 
      "plasma exchange therapy", 
      "adverse prognostic significance", 
      "cause of death", 
      "routine plasma exchange", 
      "logistic regression models", 
      "TMA diagnosis", 
      "ResultsMedian time", 
      "gastrointestinal involvement", 
      "neurological complications", 
      "thrombotic microangiopathy", 
      "creatinine levels", 
      "symptom onset", 
      "pulmonary embolism", 
      "plasma exchange", 
      "platelet count", 
      "prognostic significance", 
      "plasma therapy", 
      "myocardial infarction", 
      "nosocomial infections", 
      "ConclusionOur data", 
      "hospital setting", 
      "high risk", 
      "cardiac abnormalities", 
      "patients", 
      "haemolysis parameters", 
      "multivariate analysis", 
      "study period", 
      "therapy", 
      "diagnosis", 
      "death", 
      "adequate monitoring", 
      "mortality", 
      "survivors", 
      "cause", 
      "regression models", 
      "involvement", 
      "days", 
      "MethodsRetrospective", 
      "microangiopathy", 
      "embolism", 
      "infarction", 
      "HIV", 
      "complications", 
      "factors", 
      "stroke", 
      "infection", 
      "cancer", 
      "abnormalities", 
      "survival", 
      "outcomes", 
      "age", 
      "risk", 
      "onset", 
      "count", 
      "TMA", 
      "gender", 
      "setting", 
      "period", 
      "levels", 
      "control", 
      "cases", 
      "activity", 
      "significance", 
      "study", 
      "monitoring", 
      "data", 
      "time", 
      "analysis", 
      "model", 
      "parameters", 
      "exchange"
    ], 
    "name": "Causes and risk factors of death in patients with thrombotic microangiopathies", 
    "pagination": "1810-1817", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042628857"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00134-012-2638-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22797353"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00134-012-2638-5", 
      "https://app.dimensions.ai/details/publication/pub.1042628857"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_580.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00134-012-2638-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00134-012-2638-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00134-012-2638-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00134-012-2638-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00134-012-2638-5'


 

This table displays all metadata directly associated to this object as RDF triples.

251 TRIPLES      20 PREDICATES      117 URIs      109 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00134-012-2638-5 schema:about N0ce0f896d9554605b43f068640b1c7f6
2 N10e4133b97c44efbb45a35c60686ef76
3 N30a4987dfaeb4175926909bef8b03660
4 N3a71fd5d26e34c4392e353e958c5e15e
5 N5b8d827ee00f4f0192566ed25d975887
6 N8a74e9ccf665462c9e6fc98ed033af45
7 N8e50e4b5a25245cc8744f3dbdf8c338f
8 N930af847b02d4d138fe88376e333b3c4
9 N98493f45c6784895a6e4beb6c84e03ac
10 Naf89c532a40b41e1b8dcf0674da87a0b
11 Nb06d5b7655d14d28aea5f29cc4c80d8a
12 Ncf434a54513c48c796a7ab7921475cb1
13 Neb28c03a28a0465980d72a154a9f5349
14 Nfca8bdf057b1408291d99e984a763f87
15 anzsrc-for:11
16 anzsrc-for:1117
17 schema:author Nbc71339c59024a09b00d78cb7e5b9474
18 schema:datePublished 2012-07-14
19 schema:datePublishedReg 2012-07-14
20 schema:description PurposeAlthough plasma therapy of thrombotic micro-angiopathies (TMAs) has dramatically improved survival, the outcome remains fatal in up to 15 % of patients. We investigated the causes and risk factors of death in patients with TMA.MethodsRetrospective matched case–control national-registry study of 57 patients who died within 180 days of TMA diagnosis and 48 survivors matched on age, gender, and baseline platelet count and creatinine level. The study period was 1995–2007. Factors associated with mortality were identified using a conditional logistic regression model.ResultsMedian time from TMA symptom onset to death was 7 (5–14) days. The leading causes of death were nosocomial infections, myocardial infarction, stroke, and pulmonary embolism. Cases and controls did not differ significantly regarding haemolysis parameters, ADAMTS13 activity, or neurological or gastrointestinal involvement. TMA was more frequently related to HIV or cancer in patients who died. Compared to survivors, non-survivors more often had cardiac involvement at diagnosis (38 vs. 6 %, p = 0.03) and less often received plasma exchange therapy (60 vs. 92 %, p = 0.004). Only two factors were independently associated with mortality by multivariate analysis: cardiac involvement at diagnosis (odds ratio, 5.96; 95 % confidence interval, 1.06–33.4) and plasma exchange therapy (odds ratio, 0.25; 95 % confidence interval, 0.06–0.99).ConclusionOur data emphasise the adverse prognostic significance of cardiac abnormalities and support routine plasma exchange in patients with TMA. Given the high risk of cardiac and neurological complications, adequate monitoring should be proposed to these patients in appropriate hospital settings.
21 schema:genre article
22 schema:isAccessibleForFree false
23 schema:isPartOf N62f5f9e9793f4cafab34e5fd11dbf021
24 Nf435f1f6dfa5466fbf2cc095623744f4
25 sg:journal.1313639
26 schema:keywords ConclusionOur data
27 HIV
28 MethodsRetrospective
29 ResultsMedian time
30 TMA
31 TMA diagnosis
32 abnormalities
33 activity
34 adequate monitoring
35 adverse prognostic significance
36 age
37 analysis
38 appropriate hospital setting
39 baseline platelet count
40 cancer
41 cardiac abnormalities
42 cardiac involvement
43 cases
44 cause
45 cause of death
46 complications
47 conditional logistic regression models
48 control
49 count
50 creatinine levels
51 data
52 days
53 death
54 diagnosis
55 embolism
56 exchange
57 exchange therapy
58 factors
59 gastrointestinal involvement
60 gender
61 haemolysis parameters
62 high risk
63 hospital setting
64 infarction
65 infection
66 involvement
67 levels
68 logistic regression models
69 microangiopathy
70 model
71 monitoring
72 mortality
73 multivariate analysis
74 myocardial infarction
75 national registry study
76 neurological complications
77 nosocomial infections
78 onset
79 outcomes
80 parameters
81 patients
82 period
83 plasma exchange
84 plasma exchange therapy
85 plasma therapy
86 platelet count
87 prognostic significance
88 pulmonary embolism
89 regression models
90 risk
91 risk factors
92 routine plasma exchange
93 setting
94 significance
95 stroke
96 study
97 study period
98 survival
99 survivors
100 symptom onset
101 therapy
102 thrombotic microangiopathy
103 time
104 schema:name Causes and risk factors of death in patients with thrombotic microangiopathies
105 schema:pagination 1810-1817
106 schema:productId N3bb16c37c0cd41c399670b5670353d15
107 N443b476a956546dd98abbb32a9afc6ec
108 N8a86586e1d0f4c0a81fa7172e43dfb0a
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042628857
110 https://doi.org/10.1007/s00134-012-2638-5
111 schema:sdDatePublished 2022-09-02T15:57
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Nf85998c42cbc4496b88daf65d9d8cbe0
114 schema:url https://doi.org/10.1007/s00134-012-2638-5
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0ce0f896d9554605b43f068640b1c7f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 N10e4133b97c44efbb45a35c60686ef76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Plasma Exchange
123 rdf:type schema:DefinedTerm
124 N2754b757363e47688ab91a754104e709 rdf:first sg:person.0774634153.37
125 rdf:rest N8cb03332c6ed4f9ab311928cc76d2439
126 N30a4987dfaeb4175926909bef8b03660 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Female
128 rdf:type schema:DefinedTerm
129 N32788f082a8e4748bb3b650f19b62baf rdf:first sg:person.0625111723.58
130 rdf:rest N2754b757363e47688ab91a754104e709
131 N3a71fd5d26e34c4392e353e958c5e15e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name France
133 rdf:type schema:DefinedTerm
134 N3bb16c37c0cd41c399670b5670353d15 schema:name doi
135 schema:value 10.1007/s00134-012-2638-5
136 rdf:type schema:PropertyValue
137 N443b476a956546dd98abbb32a9afc6ec schema:name dimensions_id
138 schema:value pub.1042628857
139 rdf:type schema:PropertyValue
140 N480273b810d74d0b9ee25a3edf36aede rdf:first sg:person.01352577613.57
141 rdf:rest rdf:nil
142 N5b8d827ee00f4f0192566ed25d975887 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Cause of Death
144 rdf:type schema:DefinedTerm
145 N62f5f9e9793f4cafab34e5fd11dbf021 schema:volumeNumber 38
146 rdf:type schema:PublicationVolume
147 N689a4a47c69443efa98dd2a63c25ef92 rdf:first sg:person.01110107664.20
148 rdf:rest Nc380acab4b71458c93424ac8ced56405
149 N8a74e9ccf665462c9e6fc98ed033af45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Male
151 rdf:type schema:DefinedTerm
152 N8a86586e1d0f4c0a81fa7172e43dfb0a schema:name pubmed_id
153 schema:value 22797353
154 rdf:type schema:PropertyValue
155 N8cb03332c6ed4f9ab311928cc76d2439 rdf:first sg:person.01031271546.38
156 rdf:rest Ne0f369cb066e476094381343b016de9c
157 N8e50e4b5a25245cc8744f3dbdf8c338f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Risk Factors
159 rdf:type schema:DefinedTerm
160 N930af847b02d4d138fe88376e333b3c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Adult
162 rdf:type schema:DefinedTerm
163 N98493f45c6784895a6e4beb6c84e03ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Thrombotic Microangiopathies
165 rdf:type schema:DefinedTerm
166 Naf89c532a40b41e1b8dcf0674da87a0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Comorbidity
168 rdf:type schema:DefinedTerm
169 Nb06d5b7655d14d28aea5f29cc4c80d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Multivariate Analysis
171 rdf:type schema:DefinedTerm
172 Nbc71339c59024a09b00d78cb7e5b9474 rdf:first sg:person.01013417670.23
173 rdf:rest N689a4a47c69443efa98dd2a63c25ef92
174 Nc380acab4b71458c93424ac8ced56405 rdf:first sg:person.01036155166.50
175 rdf:rest Nd3073d31f6b742e899bbf2aea43b5ff8
176 Ncf434a54513c48c796a7ab7921475cb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Retrospective Studies
178 rdf:type schema:DefinedTerm
179 Nd3073d31f6b742e899bbf2aea43b5ff8 rdf:first sg:person.0705705127.00
180 rdf:rest N32788f082a8e4748bb3b650f19b62baf
181 Ne0f369cb066e476094381343b016de9c rdf:first sg:person.01073441000.64
182 rdf:rest N480273b810d74d0b9ee25a3edf36aede
183 Neb28c03a28a0465980d72a154a9f5349 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Case-Control Studies
185 rdf:type schema:DefinedTerm
186 Nf435f1f6dfa5466fbf2cc095623744f4 schema:issueNumber 11
187 rdf:type schema:PublicationIssue
188 Nf85998c42cbc4496b88daf65d9d8cbe0 schema:name Springer Nature - SN SciGraph project
189 rdf:type schema:Organization
190 Nfca8bdf057b1408291d99e984a763f87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Humans
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
197 schema:name Public Health and Health Services
198 rdf:type schema:DefinedTerm
199 sg:journal.1313639 schema:issn 0342-4642
200 1432-1238
201 schema:name Intensive Care Medicine
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01013417670.23 schema:affiliation grid-institutes:grid.50550.35
205 schema:familyName Peigne
206 schema:givenName Vincent
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013417670.23
208 rdf:type schema:Person
209 sg:person.01031271546.38 schema:affiliation grid-institutes:grid.50550.35
210 schema:familyName Coppo
211 schema:givenName Paul
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031271546.38
213 rdf:type schema:Person
214 sg:person.01036155166.50 schema:affiliation grid-institutes:grid.50550.35
215 schema:familyName Resche Rigon
216 schema:givenName Matthieu
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50
218 rdf:type schema:Person
219 sg:person.01073441000.64 schema:affiliation grid-institutes:grid.50550.35
220 schema:familyName Veyradier
221 schema:givenName Agnès
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073441000.64
223 rdf:type schema:Person
224 sg:person.01110107664.20 schema:affiliation grid-institutes:grid.50550.35
225 schema:familyName Perez
226 schema:givenName Pierre
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110107664.20
228 rdf:type schema:Person
229 sg:person.01352577613.57 schema:affiliation grid-institutes:grid.50550.35
230 schema:familyName Azoulay
231 schema:givenName Elie
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352577613.57
233 rdf:type schema:Person
234 sg:person.0625111723.58 schema:affiliation grid-institutes:grid.50550.35
235 schema:familyName Canet
236 schema:givenName Emmanuel
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625111723.58
238 rdf:type schema:Person
239 sg:person.0705705127.00 schema:affiliation grid-institutes:grid.50550.35
240 schema:familyName Mariotte
241 schema:givenName Eric
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705705127.00
243 rdf:type schema:Person
244 sg:person.0774634153.37 schema:affiliation grid-institutes:grid.50550.35
245 schema:familyName Mira
246 schema:givenName Jean-Paul
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774634153.37
248 rdf:type schema:Person
249 grid-institutes:grid.50550.35 schema:alternateName AP-HP, Hôpital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France
250 schema:name AP-HP, Hôpital Saint-Louis Medical ICU, 1 Avenue Claude Vellefaux, 75010, Paris, France
251 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...